IART logo

IART Stock Overview

Profile

Full Name:

Integra LifeSciences Holdings Corporation

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

August 16, 1995

Indexes:

Not included

Website:

http://www.integralife.com

Description:

Integra LifeSciences Holdings Corporation is a technology medical company whose main activity is the development, production, and sale of surgical implants and medical instruments for use in neurosurgery, limb reconstruction, orthopedics, and general surgery. The Codman Specialty Surgical segment specializes in surgical products, including a wide range of surgical implants and instruments. The Orthopedics and Tissue Technologies segment focuses on regenerative technologies for the treatment of acute and chronic wounds; tools for surgical tissue regeneration, including hernia repair, peripheral nerve repair and protection, and tendon repair. The company was founded in 1989, with its headquarters in Princeton, New Jersey.

Key Details

Price

$23.00

Market Cap

$1.78 B(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.61 B(+4.47% YoY)

Annual EPS

-$0.09(-110.71% YoY)

PE Ratio

-

Annual ROE

-0.44%

Annual Debt To Equity

1.17

Beta

0.69

Events Calendar

Earnings

Next earnings date:

May 6, 2025

Recent quarterly earnings:

Feb 25, 2025

Recent annual earnings:

Feb 25, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 4, 2017

Analyst ratings

Recent major analysts updates

Feb 26, 25 Citizens Capital Markets
Market Outperform
Nov 5, 24 Citigroup
Sell
Oct 14, 24 Truist Securities
Hold
Oct 7, 24 BTIG
Neutral
Oct 7, 24 B of A Securities
Underperform
Oct 1, 24 Citigroup
Sell
Aug 28, 24 BTIG
Sell
Aug 22, 24 Citigroup
Sell
Jul 30, 24 Truist Securities
Hold
Jul 30, 24 JMP Securities
Market Outperform

Screeners with IART included

US stocks
Stocks below SMA 200
Stocks recommended to hold
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies
Companies with buyback
Best performing stocks last 15 years
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$23.00
IART price is $23.00

Price All-time High

$76.63
IART price is currently -69.99% below its historical high of $76.63

Price Analysts Target

$24.50
IART price is currently -6.12% lower than the consensus analysts' forecast

Price Most Recent Change

+4.4%
IART price was up +4.4% on Mar 7, 2025

Price YTD Change

+1.41%
IART price is up +1.41% since January 1st

Price 3-Year Change

-66.09%
IART price is down -66.09% over the past 3 years

Market cap

Market Cap

$1.78 B
IART market capitalization is $1.78 billion

Market Cap 3-Year Change

-68.54%
IART market capitalization is down -68.54% over the past 3 years

Market Cap All-time High

$6.48 B
IART market capitalization is currently -72.59% below its historical high of $6.48 billion

Market Cap Sector Rank

80.74%
IART market capitalization is higher than 80.74% of companies in Healthcare sector

Technical

Beta

0.69
IART beta is 0.69

200-day SMA

$23.78
IART price is currently -3.29% below its 200-day simple moving average

14-day RSI

47.67
IART 14-day relative strength index is 47.67

30-day Relative Volume

0.87
IART 30-day relative volume is 0.87

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.61 B
IART annual revenue is $1.61 billion

Annual Revenue Analysts Estimate

$1.68 B
IART annual revenue is currently -4.10% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+4.47%
IART annual revenue is up +4.47% year-on-year

Annual Revenue Sector Rank

83.69%
IART annual revenue is higher than 83.69% of companies in Healthcare sector

Profit

Annual Gross Profit

$882.06 M
IART annual gross profit is $882.06 million

Annual Gross Margin

54.77%
IART annual gross profit margin is 54.77%

Annual Operating Profit

$28.41 M
IART annual operating income is $28.41 million

Annual Operating Margin

1.76%
IART annual operating profit margin is 1.76%

Annual Net Income

-$6.94 M
IART annual net profit is -$6.94 million

Annual Net Margin

-0.43%
IART annual net profit margin is -0.43%

EPS

Annual EPS

-$0.09
IART annual earnings per share is -$0.09

Annual EPS Analysts Estimate

$2.46
IART annual earnings per share is currently -103.65% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-110.71%
IART annual earnings per share is down -110.71% year-on-year

Annual EPS Sector Rank

80.94%
IART annual earnings per share is higher than 80.94% of companies in Healthcare sector

ROA & ROE

Annual ROA

-0.18%
IART annual return on assets is -0.18%

Annual ROE

-0.44%
IART annual return on equity is -0.44%

EBIT & EBITDA

Annual EBIT

$52.40 M
IART annual earnings before interest & taxes is $52.40 million

Annual EBITDA

$193.29 M
IART annual EBITDA is $193.29 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
IART price to earnings ratio value is unknown

PE Ratio Sector Rank

-
IART price to earnings ratio is unknown

PB Ratio

PB Ratio

1.15
IART price to book ratio is 1.15

PB Ratio Sector Rank

46.05%
IART price to book ratio is higher than 46.05% of companies in Healthcare sector

PS Ratio

PS Ratio

1.10
IART price to sales ratio is 1.10

PS Ratio Sector Rank

27.12%
IART price to sales ratio is higher than 27.12% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.51 B
IART enterprise value is $3.51 billion

Enterprise Value Sector Rank

85.73%
IART enterprise value is higher than 85.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

18.18
IART EV/EBITDA is 18.18

EV/EBITDA Sector Rank

89.32%
IART EV/EBITDA is higher than 89.32% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.17
IART annual current ratio is 1.17

Annual Quick Ratio

0.71
IART annual quick ratio is 0.71

Leverage

Annual Debt To Equity

1.17
IART annual debt to equity ratio is 1.17

Annual Interest Coverage Ratio

0.74
IART annual interest coverage ratio is 0.74

Risk & Stability

Piotroski F-Score

4
IART piotroski f-score is 4

Altman Z-Score

1.24
IART altman z-score is 1.24

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$4.04 B
IART annual total assets is $4.04 billion

Annual Non Current Assets

$2.96 B
IART annual long term assets is $2.96 billion

Annual Current Assets

$1.08 B
IART annual total current assets is $1.08 billion

Annual Cash & Cash Equivalents

$246.38 M
IART annual cash & cash equivalents is $246.38 million

Equity

Annual Book Value

$1.55 B
IART annual book value is $1.55 billion

Annual Working Capital

$159.56 M
IART annual working capital is $159.56 million

Liabilities

Annual Total Liabilities

$2.49 B
IART annual total liabilities is $2.49 billion

Annual Total Long Term Liabilities

$1.57 B
IART annual total long term liabilities is $1.57 billion

Annual Current Liabilities

$922.13 M
IART annual total current liabilities is $922.13 million

Annual Accounts Payable

$82.50 M
IART annual accounts payable is $82.50 million

Debt

Annual Total Debt

$1.98 B
IART annual total debt is $1.98 billion

Annual Total Debt 1-Year Change

+18.01%
IART annual total debt is up +18.01% year-on-year

Annual Long Term Debt

$1.36 B
IART annual long term debt is $1.36 billion

Annual Short Term Debt

$621.62 M
IART annual short term debt is $621.62 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$1.58 B
IART annual total expenses is $1.58 billion

Annual Operating Expenses

$853.65 M
IART annual total operating expenses is $853.65 million

Annual Cost Of Goods Sold

$728.47 M
IART annual cost of goods sold is $728.47 million

Annual SGA

$716.98 M
IART annual SGA is $716.98 million

Annual D&A

$140.89 M
IART annual depreciation & amortization is $140.89 million

Annual Interest Expense

$70.63 M
IART annual interest expense is $70.63 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$129.38 M
IART annual cash flow from operations is $129.38 million

Annual CFO 1-Year Change

-7.55%
IART annual cash flow from operations is down -7.55% year-on-year

Annual CFI

-$390.81 M
IART annual cash flow from investing activities is -$390.81 million

Annual CFI 1-Year Change

-314.97%
IART annual cash flow from investing activities is down -314.97% year-on-year

Annual CFF

$237.86 M
IART annual cash flow from financing activities is $237.86 million

Annual CFF 1-Year Change

+203.45%
IART annual cash flow from financing activities is up +203.45% year-on-year

Free CashFlow

Annual FCF

$15.01 M
IART annual free cash flow is $15.01 million

Annual FCF 1-Year Change

-79.46%
IART annual free cash flow is down -79.46% year-on-year

CAPEX

Annual CAPEX

$114.37 M
IART annual capital expenditures is $114.37 million

Annual CAPEX 1-Year Change

+71.05%
IART annual capital expenditures is up +71.05% year-on-year

Institutional Ownership

Similar stocks

PGNY logo
Progyny (PGNY)
ADUS logo
Addus HomeCare (ADUS)
DVAX logo
Dynavax Technologies (DVAX)
GDRX logo
GoodRx Holdings (GDRX)
GLPG logo
Galapagos NV (GLPG)
TARS logo
Tarsus Pharmaceuticals (TARS)
ARQT logo
Arcutis Biotherapeutics (ARQT)
CGON logo
CG Oncology (CGON)
CERT logo
Certara (CERT)

FAQ

  • What is the ticker symbol for Integra LifeSciences Holdings?
  • Does Integra LifeSciences Holdings pay dividends?
  • What sector is Integra LifeSciences Holdings in?
  • What industry is Integra LifeSciences Holdings in?
  • What country is Integra LifeSciences Holdings based in?
  • When did Integra LifeSciences Holdings go public?
  • Is Integra LifeSciences Holdings in the S&P 500?
  • Is Integra LifeSciences Holdings in the NASDAQ 100?
  • Is Integra LifeSciences Holdings in the Dow Jones?
  • When was Integra LifeSciences Holdings's last earnings report?
  • When does Integra LifeSciences Holdings report earnings?
  • Should I buy Integra LifeSciences Holdings stock now?

What is the ticker symbol for Integra LifeSciences Holdings?

The ticker symbol for Integra LifeSciences Holdings is NASDAQ:IART

Does Integra LifeSciences Holdings pay dividends?

No, Integra LifeSciences Holdings does not pay dividends

What sector is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Healthcare sector

What industry is Integra LifeSciences Holdings in?

Integra LifeSciences Holdings is in the Medical Devices industry

What country is Integra LifeSciences Holdings based in?

Integra LifeSciences Holdings is headquartered in United States

When did Integra LifeSciences Holdings go public?

Integra LifeSciences Holdings's initial public offering (IPO) was on August 16, 1995

Is Integra LifeSciences Holdings in the S&P 500?

No, Integra LifeSciences Holdings is not included in the S&P 500 index

Is Integra LifeSciences Holdings in the NASDAQ 100?

No, Integra LifeSciences Holdings is not included in the NASDAQ 100 index

Is Integra LifeSciences Holdings in the Dow Jones?

No, Integra LifeSciences Holdings is not included in the Dow Jones index

When was Integra LifeSciences Holdings's last earnings report?

Integra LifeSciences Holdings's most recent earnings report was on Feb 25, 2025

When does Integra LifeSciences Holdings report earnings?

The next expected earnings date for Integra LifeSciences Holdings is May 6, 2025

Should I buy Integra LifeSciences Holdings stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions